Illumina, Janssen Biotech form strategic partnership to develop precision medicines (Genomeweb)
"Illumina announced on Wednesday at the World CDx Summit in London that it has forged a long-term strategic collaboration with Janssen Biotech to accelerate the development of precision medicines...The collaboration aims to utilize Illumina's portfolio of resources, including AI-based genome interpretation tools, whole-genome sequencing, and multiomic analysis services, according to the company...As part of the partnership, Illumina and Janssen will codevelop CDx programs on Illumina's TruSight Oncology Comprehensive assay, a single test that assesses multiple tumor genes and biomarkers in a patient's cancer."